1200011M11Rik Activators
1200011M11Rik Activators encompass a diverse range of chemical compounds that indirectly augment the functional activity of 1200011M11Rik through distinct signaling pathways. For instance, Forskolin and Ionomycin, by increasing intracellular cAMP and calciumlevels respectively, may indirectly enhance 1200011M11Rik's activity through the activation of PKA and calcium-dependent protein kinases that could phosphorylate and regulate this protein's function. Similarly, the application of PMA activates PKC, which has the potential to phosphorylate 1200011M11Rik or related proteins within its pathway, suggesting a method of enhancement if 1200011M11Rik is regulated by PKC signaling. LY294002 and U0126, by modulating the PI3K/AKT and ERK/MAPK pathways respectively, could lead to an increase in 1200011M11Rik activity by altering signaling dynamics that affect its function. Additionally, SB203580's inhibition of p38 MAPK might shift the cellular signaling balance to favor 1200011M11Rik's activation, assuming a regulatory relationship exists.
The activity of 1200011M11Rik could also be influenced by compounds that affect kinase activity and calcium signaling. EGCG, as a kinase inhibitor, may upregulate 1200011M11Rik activity by decreasing inhibitory phosphorylations, assuming the inhibited kinases negatively regulate 1200011M11Rik. Sphingosine-1-phosphate and Thapsigargin, through modulation of lipid signaling and SERCA inhibition respectively, might enhance the activity of 1200011M11Rik via the initiation of signaling cascades that 1200011M11Rik is a part of or influenced by. Genistein's inhibition of tyrosine kinases, A23187's (Calcimycin) elevation of intracellular calcium, and Staurosporine's broad-spectrum kinase inhibition, while counterintuitive, could each lead to a selective increase in 1200011M11Rik activity by reducing competitive or negative regulatory signaling mechanisms, thus providing potential avenues for the activation of this protein's functional pathways. Together, these activators represent a complex network of regulatory mechanisms, each with the potential to influence the cellular functions associated with 1200011M11Rik.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which could phosphorylate 1200011M11Rik or proteins in its pathway, enhancing its activity if it is regulated by PKC signaling. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
A calcium ionophore that increases intracellular calcium concentrations, potentially modulating calcium-dependent protein kinases that could phosphorylate and activate 1200011M11Rik. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor that may enhance the activity of 1200011M11Rik by altering the PI3K/AKT pathway, which could have downstream effects on 1200011M11Rik if it is part of this signaling cascade. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
An inhibitor of p38 MAPK, which may shift the balance of cellular signaling to favor the activation of 1200011M11Rik if it is negatively regulated by p38 MAPK or its downstream effectors. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
This polyphenol inhibits several kinases and may upregulate 1200011M11Rik activity by reducing inhibitory phosphorylations if such kinases negatively regulate 1200011M11Rik. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
It acts on sphingosine-1-phosphate receptors and could enhance the activity of 1200011M11Rik by engaging in signaling pathways that converge on or modulate the function of 1200011M11Rik. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
An inhibitor of the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), leading to increased cytosolic calcium levels which might activate calcium-dependent kinases that enhance 1200011M11Rik activity. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
This tyrosine kinase inhibitor could potentiate the activity of 1200011M11Rik by reducing competitive tyrosine kinase signaling that otherwise attenuates 1200011M11Rik's function. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A calcium ionophore that increases intracellular calcium, which could activate signaling cascades involving calmodulin or other calcium-binding proteins that affect 1200011M11Rik. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Although a broad-spectrum kinase inhibitor, it could selectively enhance 1200011M11Rik activity by inhibiting kinases that negatively regulate 1200011M11Rik or its associated pathways. | ||||||